The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Itraconazole (Sporanox), a new generation of triazole, is a highly effective broad-spectrum antifungal drug that can inhibit the synthesis of ergosterol by combining with fungal cytochrome P450 isoenzyme.This product is effective for tinea dermatia, candida, cryptococcus neoforme, choridia spore, aspergillus, histoplasmosis, paracardium brasileum, schencosporium, fungi, mycoderma, dermatitis spore, etc.
The global Sporanox market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sporanox is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sporanox is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sporanox in Yeast Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sporanox include Abbott, Johnson & Johnson, Smilax, Ultratech India, Nifty Labs, Nosch Labs, Shouguang Fukang Pharmaceutical, Lepu Pharmaceuticals and Harbin Sanlian Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sporanox, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sporanox.
Report Scope
The Sporanox market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sporanox market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sporanox companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Johnson & Johnson
Smilax
Ultratech India
Nifty Labs
Nosch Labs
Shouguang Fukang Pharmaceutical
Lepu Pharmaceuticals
Harbin Sanlian Pharmaceutical
Kangzhi Pharmaceutical
Shanghai Modern Hasen Pharmaceutical
Lepu Pharmaceutical
Tianjin Lisheng Pharmaceutical
Chengdu Beite Pharmaceutical
Xi'an Yangsen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Segment by Type
Injection
Solution
Tablets
Capsule
Granules
Segment by Application
Yeast Disease
Histoplasmosis
Ringworm Of The Nails
Systemic Infection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sporanox companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Itraconazole (Sporanox), a new generation of triazole, is a highly effective broad-spectrum antifungal drug that can inhibit the synthesis of ergosterol by combining with fungal cytochrome P450 isoenzyme.This product is effective for tinea dermatia, candida, cryptococcus neoforme, choridia spore, aspergillus, histoplasmosis, paracardium brasileum, schencosporium, fungi, mycoderma, dermatitis spore, etc.
The global Sporanox market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sporanox is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sporanox is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sporanox in Yeast Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sporanox include Abbott, Johnson & Johnson, Smilax, Ultratech India, Nifty Labs, Nosch Labs, Shouguang Fukang Pharmaceutical, Lepu Pharmaceuticals and Harbin Sanlian Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sporanox, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sporanox.
Report Scope
The Sporanox market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sporanox market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sporanox companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Johnson & Johnson
Smilax
Ultratech India
Nifty Labs
Nosch Labs
Shouguang Fukang Pharmaceutical
Lepu Pharmaceuticals
Harbin Sanlian Pharmaceutical
Kangzhi Pharmaceutical
Shanghai Modern Hasen Pharmaceutical
Lepu Pharmaceutical
Tianjin Lisheng Pharmaceutical
Chengdu Beite Pharmaceutical
Xi'an Yangsen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Segment by Type
Injection
Solution
Tablets
Capsule
Granules
Segment by Application
Yeast Disease
Histoplasmosis
Ringworm Of The Nails
Systemic Infection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sporanox companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sporanox Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Solution
1.2.4 Tablets
1.2.5 Capsule
1.2.6 Granules
1.3 Market by Application
1.3.1 Global Sporanox Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Yeast Disease
1.3.3 Histoplasmosis
1.3.4 Ringworm Of The Nails
1.3.5 Systemic Infection
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sporanox Market Perspective (2019-2030)
2.2 Sporanox Growth Trends by Region
2.2.1 Global Sporanox Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sporanox Historic Market Size by Region (2019-2024)
2.2.3 Sporanox Forecasted Market Size by Region (2025-2030)
2.3 Sporanox Market Dynamics
2.3.1 Sporanox Industry Trends
2.3.2 Sporanox Market Drivers
2.3.3 Sporanox Market Challenges
2.3.4 Sporanox Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sporanox Players by Revenue
3.1.1 Global Top Sporanox Players by Revenue (2019-2024)
3.1.2 Global Sporanox Revenue Market Share by Players (2019-2024)
3.2 Global Sporanox Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sporanox Revenue
3.4 Global Sporanox Market Concentration Ratio
3.4.1 Global Sporanox Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sporanox Revenue in 2023
3.5 Sporanox Key Players Head office and Area Served
3.6 Key Players Sporanox Product Solution and Service
3.7 Date of Enter into Sporanox Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sporanox Breakdown Data by Type
4.1 Global Sporanox Historic Market Size by Type (2019-2024)
4.2 Global Sporanox Forecasted Market Size by Type (2025-2030)
5 Sporanox Breakdown Data by Application
5.1 Global Sporanox Historic Market Size by Application (2019-2024)
5.2 Global Sporanox Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sporanox Market Size (2019-2030)
6.2 North America Sporanox Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sporanox Market Size by Country (2019-2024)
6.4 North America Sporanox Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sporanox Market Size (2019-2030)
7.2 Europe Sporanox Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sporanox Market Size by Country (2019-2024)
7.4 Europe Sporanox Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sporanox Market Size (2019-2030)
8.2 Asia-Pacific Sporanox Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sporanox Market Size by Region (2019-2024)
8.4 Asia-Pacific Sporanox Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sporanox Market Size (2019-2030)
9.2 Latin America Sporanox Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sporanox Market Size by Country (2019-2024)
9.4 Latin America Sporanox Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sporanox Market Size (2019-2030)
10.2 Middle East & Africa Sporanox Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sporanox Market Size by Country (2019-2024)
10.4 Middle East & Africa Sporanox Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Sporanox Introduction
11.1.4 Abbott Revenue in Sporanox Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Sporanox Introduction
11.2.4 Johnson & Johnson Revenue in Sporanox Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Smilax
11.3.1 Smilax Company Detail
11.3.2 Smilax Business Overview
11.3.3 Smilax Sporanox Introduction
11.3.4 Smilax Revenue in Sporanox Business (2019-2024)
11.3.5 Smilax Recent Development
11.4 Ultratech India
11.4.1 Ultratech India Company Detail
11.4.2 Ultratech India Business Overview
11.4.3 Ultratech India Sporanox Introduction
11.4.4 Ultratech India Revenue in Sporanox Business (2019-2024)
11.4.5 Ultratech India Recent Development
11.5 Nifty Labs
11.5.1 Nifty Labs Company Detail
11.5.2 Nifty Labs Business Overview
11.5.3 Nifty Labs Sporanox Introduction
11.5.4 Nifty Labs Revenue in Sporanox Business (2019-2024)
11.5.5 Nifty Labs Recent Development
11.6 Nosch Labs
11.6.1 Nosch Labs Company Detail
11.6.2 Nosch Labs Business Overview
11.6.3 Nosch Labs Sporanox Introduction
11.6.4 Nosch Labs Revenue in Sporanox Business (2019-2024)
11.6.5 Nosch Labs Recent Development
11.7 Shouguang Fukang Pharmaceutical
11.7.1 Shouguang Fukang Pharmaceutical Company Detail
11.7.2 Shouguang Fukang Pharmaceutical Business Overview
11.7.3 Shouguang Fukang Pharmaceutical Sporanox Introduction
11.7.4 Shouguang Fukang Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.7.5 Shouguang Fukang Pharmaceutical Recent Development
11.8 Lepu Pharmaceuticals
11.8.1 Lepu Pharmaceuticals Company Detail
11.8.2 Lepu Pharmaceuticals Business Overview
11.8.3 Lepu Pharmaceuticals Sporanox Introduction
11.8.4 Lepu Pharmaceuticals Revenue in Sporanox Business (2019-2024)
11.8.5 Lepu Pharmaceuticals Recent Development
11.9 Harbin Sanlian Pharmaceutical
11.9.1 Harbin Sanlian Pharmaceutical Company Detail
11.9.2 Harbin Sanlian Pharmaceutical Business Overview
11.9.3 Harbin Sanlian Pharmaceutical Sporanox Introduction
11.9.4 Harbin Sanlian Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.9.5 Harbin Sanlian Pharmaceutical Recent Development
11.10 Kangzhi Pharmaceutical
11.10.1 Kangzhi Pharmaceutical Company Detail
11.10.2 Kangzhi Pharmaceutical Business Overview
11.10.3 Kangzhi Pharmaceutical Sporanox Introduction
11.10.4 Kangzhi Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.10.5 Kangzhi Pharmaceutical Recent Development
11.11 Shanghai Modern Hasen Pharmaceutical
11.11.1 Shanghai Modern Hasen Pharmaceutical Company Detail
11.11.2 Shanghai Modern Hasen Pharmaceutical Business Overview
11.11.3 Shanghai Modern Hasen Pharmaceutical Sporanox Introduction
11.11.4 Shanghai Modern Hasen Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.11.5 Shanghai Modern Hasen Pharmaceutical Recent Development
11.12 Lepu Pharmaceutical
11.12.1 Lepu Pharmaceutical Company Detail
11.12.2 Lepu Pharmaceutical Business Overview
11.12.3 Lepu Pharmaceutical Sporanox Introduction
11.12.4 Lepu Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.12.5 Lepu Pharmaceutical Recent Development
11.13 Tianjin Lisheng Pharmaceutical
11.13.1 Tianjin Lisheng Pharmaceutical Company Detail
11.13.2 Tianjin Lisheng Pharmaceutical Business Overview
11.13.3 Tianjin Lisheng Pharmaceutical Sporanox Introduction
11.13.4 Tianjin Lisheng Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.13.5 Tianjin Lisheng Pharmaceutical Recent Development
11.14 Chengdu Beite Pharmaceutical
11.14.1 Chengdu Beite Pharmaceutical Company Detail
11.14.2 Chengdu Beite Pharmaceutical Business Overview
11.14.3 Chengdu Beite Pharmaceutical Sporanox Introduction
11.14.4 Chengdu Beite Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.14.5 Chengdu Beite Pharmaceutical Recent Development
11.15 Xi'an Yangsen Pharmaceutical
11.15.1 Xi'an Yangsen Pharmaceutical Company Detail
11.15.2 Xi'an Yangsen Pharmaceutical Business Overview
11.15.3 Xi'an Yangsen Pharmaceutical Sporanox Introduction
11.15.4 Xi'an Yangsen Pharmaceutical Revenue in Sporanox Business (2019-2024)
11.15.5 Xi'an Yangsen Pharmaceutical Recent Development
11.16 Shandong Luoxin Pharmaceutical Group
11.16.1 Shandong Luoxin Pharmaceutical Group Company Detail
11.16.2 Shandong Luoxin Pharmaceutical Group Business Overview
11.16.3 Shandong Luoxin Pharmaceutical Group Sporanox Introduction
11.16.4 Shandong Luoxin Pharmaceutical Group Revenue in Sporanox Business (2019-2024)
11.16.5 Shandong Luoxin Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sporanox Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Solution
Table 4. Key Players of Tablets
Table 5. Key Players of Capsule
Table 6. Key Players of Granules
Table 7. Global Sporanox Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Sporanox Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Sporanox Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Sporanox Market Share by Region (2019-2024)
Table 11. Global Sporanox Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Sporanox Market Share by Region (2025-2030)
Table 13. Sporanox Market Trends
Table 14. Sporanox Market Drivers
Table 15. Sporanox Market Challenges
Table 16. Sporanox Market Restraints
Table 17. Global Sporanox Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Sporanox Market Share by Players (2019-2024)
Table 19. Global Top Sporanox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sporanox as of 2023)
Table 20. Ranking of Global Top Sporanox Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Sporanox Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sporanox Product Solution and Service
Table 24. Date of Enter into Sporanox Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sporanox Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Sporanox Revenue Market Share by Type (2019-2024)
Table 28. Global Sporanox Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Sporanox Revenue Market Share by Type (2025-2030)
Table 30. Global Sporanox Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Sporanox Revenue Market Share by Application (2019-2024)
Table 32. Global Sporanox Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Sporanox Revenue Market Share by Application (2025-2030)
Table 34. North America Sporanox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Sporanox Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Sporanox Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Sporanox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Sporanox Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Sporanox Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Sporanox Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Sporanox Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Sporanox Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Sporanox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Sporanox Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Sporanox Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Sporanox Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Sporanox Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Sporanox Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Company Detail
Table 50. Abbott Business Overview
Table 51. Abbott Sporanox Product
Table 52. Abbott Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 53. Abbott Recent Development
Table 54. Johnson & Johnson Company Detail
Table 55. Johnson & Johnson Business Overview
Table 56. Johnson & Johnson Sporanox Product
Table 57. Johnson & Johnson Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 58. Johnson & Johnson Recent Development
Table 59. Smilax Company Detail
Table 60. Smilax Business Overview
Table 61. Smilax Sporanox Product
Table 62. Smilax Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 63. Smilax Recent Development
Table 64. Ultratech India Company Detail
Table 65. Ultratech India Business Overview
Table 66. Ultratech India Sporanox Product
Table 67. Ultratech India Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 68. Ultratech India Recent Development
Table 69. Nifty Labs Company Detail
Table 70. Nifty Labs Business Overview
Table 71. Nifty Labs Sporanox Product
Table 72. Nifty Labs Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 73. Nifty Labs Recent Development
Table 74. Nosch Labs Company Detail
Table 75. Nosch Labs Business Overview
Table 76. Nosch Labs Sporanox Product
Table 77. Nosch Labs Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 78. Nosch Labs Recent Development
Table 79. Shouguang Fukang Pharmaceutical Company Detail
Table 80. Shouguang Fukang Pharmaceutical Business Overview
Table 81. Shouguang Fukang Pharmaceutical Sporanox Product
Table 82. Shouguang Fukang Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 83. Shouguang Fukang Pharmaceutical Recent Development
Table 84. Lepu Pharmaceuticals Company Detail
Table 85. Lepu Pharmaceuticals Business Overview
Table 86. Lepu Pharmaceuticals Sporanox Product
Table 87. Lepu Pharmaceuticals Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 88. Lepu Pharmaceuticals Recent Development
Table 89. Harbin Sanlian Pharmaceutical Company Detail
Table 90. Harbin Sanlian Pharmaceutical Business Overview
Table 91. Harbin Sanlian Pharmaceutical Sporanox Product
Table 92. Harbin Sanlian Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 93. Harbin Sanlian Pharmaceutical Recent Development
Table 94. Kangzhi Pharmaceutical Company Detail
Table 95. Kangzhi Pharmaceutical Business Overview
Table 96. Kangzhi Pharmaceutical Sporanox Product
Table 97. Kangzhi Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 98. Kangzhi Pharmaceutical Recent Development
Table 99. Shanghai Modern Hasen Pharmaceutical Company Detail
Table 100. Shanghai Modern Hasen Pharmaceutical Business Overview
Table 101. Shanghai Modern Hasen Pharmaceutical Sporanox Product
Table 102. Shanghai Modern Hasen Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 103. Shanghai Modern Hasen Pharmaceutical Recent Development
Table 104. Lepu Pharmaceutical Company Detail
Table 105. Lepu Pharmaceutical Business Overview
Table 106. Lepu Pharmaceutical Sporanox Product
Table 107. Lepu Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 108. Lepu Pharmaceutical Recent Development
Table 109. Tianjin Lisheng Pharmaceutical Company Detail
Table 110. Tianjin Lisheng Pharmaceutical Business Overview
Table 111. Tianjin Lisheng Pharmaceutical Sporanox Product
Table 112. Tianjin Lisheng Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 113. Tianjin Lisheng Pharmaceutical Recent Development
Table 114. Chengdu Beite Pharmaceutical Company Detail
Table 115. Chengdu Beite Pharmaceutical Business Overview
Table 116. Chengdu Beite Pharmaceutical Sporanox Product
Table 117. Chengdu Beite Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 118. Chengdu Beite Pharmaceutical Recent Development
Table 119. Xi'an Yangsen Pharmaceutical Company Detail
Table 120. Xi'an Yangsen Pharmaceutical Business Overview
Table 121. Xi'an Yangsen Pharmaceutical Sporanox Product
Table 122. Xi'an Yangsen Pharmaceutical Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 123. Xi'an Yangsen Pharmaceutical Recent Development
Table 124. Shandong Luoxin Pharmaceutical Group Company Detail
Table 125. Shandong Luoxin Pharmaceutical Group Business Overview
Table 126. Shandong Luoxin Pharmaceutical Group Sporanox Product
Table 127. Shandong Luoxin Pharmaceutical Group Revenue in Sporanox Business (2019-2024) & (US$ Million)
Table 128. Shandong Luoxin Pharmaceutical Group Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sporanox Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sporanox Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Solution Features
Figure 5. Tablets Features
Figure 6. Capsule Features
Figure 7. Granules Features
Figure 8. Global Sporanox Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Sporanox Market Share by Application: 2023 VS 2030
Figure 10. Yeast Disease Case Studies
Figure 11. Histoplasmosis Case Studies
Figure 12. Ringworm Of The Nails Case Studies
Figure 13. Systemic Infection Case Studies
Figure 14. Sporanox Report Years Considered
Figure 15. Global Sporanox Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Sporanox Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Sporanox Market Share by Region: 2023 VS 2030
Figure 18. Global Sporanox Market Share by Players in 2023
Figure 19. Global Top Sporanox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sporanox as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Sporanox Revenue in 2023
Figure 21. North America Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Sporanox Market Share by Country (2019-2030)
Figure 23. United States Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Sporanox Market Share by Country (2019-2030)
Figure 27. Germany Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Sporanox Market Share by Region (2019-2030)
Figure 35. China Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Sporanox Market Share by Country (2019-2030)
Figure 43. Mexico Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Sporanox Market Share by Country (2019-2030)
Figure 47. Turkey Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Sporanox Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 51. Smilax Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 52. Ultratech India Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 53. Nifty Labs Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 54. Nosch Labs Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 55. Shouguang Fukang Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 56. Lepu Pharmaceuticals Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 57. Harbin Sanlian Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 58. Kangzhi Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 59. Shanghai Modern Hasen Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 60. Lepu Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 61. Tianjin Lisheng Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 62. Chengdu Beite Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 63. Xi'an Yangsen Pharmaceutical Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 64. Shandong Luoxin Pharmaceutical Group Revenue Growth Rate in Sporanox Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
